# NCT00003389 (NCT00003389)

> Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00003389
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Eastern Cooperative Oncology Group
- Conditions: Lymphoma
- Interventions: Doxorubicin; Bleomycin; Vinblastine; Dacarbazine; Vincristine; Mechlorethamine; Etoposide; Prednisone; Cyclophosphamide; Radiotherapy
- Enrollment: 854
- Primary outcome: Failure-free Survival at 5 Years

## Commentary we found

- Podcasts: 3
- YouTube: 2
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct00003389